These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15549379)

  • 1. Etanercept plus colchicine treatment in a child with tumour necrosis factor receptor-associated periodic syndrome abolishes auto-inflammatory episodes without normalising the subclinical acute phase response.
    Aróstegui JI; Solís P; Aldea A; Cantero T; Rius J; Bahíllo P; Plaza S; Vives J; Gómez S; Yagüe J
    Eur J Pediatr; 2005 Jan; 164(1):13-6. PubMed ID: 15549379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of anti-tumour necrosis factor receptor superfamily 1B fusion protein, and case study of anti-tumour necrosis factor receptor superfamily 1A fusion protein, in tumour necrosis factor receptor associated periodic syndrome (TRAPS): clinical and laboratory findings in a series of seven patients.
    Drewe E; McDermott EM; Powell PT; Isaacs JD; Powell RJ
    Rheumatology (Oxford); 2003 Feb; 42(2):235-9. PubMed ID: 12595616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of renal amyloidosis with etanercept in tumour necrosis factor receptor-associated periodic syndrome.
    Drewe E; Huggins ML; Morgan AG; Cassidy MJ; Powell RJ
    Rheumatology (Oxford); 2004 Nov; 43(11):1405-8. PubMed ID: 15316120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and functional characterisation of a novel TNFRSF1A c.605T>A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment.
    Stojanov S; Dejaco C; Lohse P; Huss K; Duftner C; Belohradsky BH; Herold M; Schirmer M
    Ann Rheum Dis; 2008 Sep; 67(9):1292-8. PubMed ID: 18180277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNF receptor-associated periodic syndrome (TRAPS): description of a novel TNFRSF1A mutation and response to etanercept.
    Jesus AA; Oliveira JB; Aksentijevich I; Fujihira E; Carneiro-Sampaio MM; Duarte AJ; Silva CA
    Eur J Pediatr; 2008 Dec; 167(12):1421-5. PubMed ID: 18408954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Favorable preliminary experience with etanercept in two patients with the hyperimmunoglobulinemia D and periodic fever syndrome.
    Takada K; Aksentijevich I; Mahadevan V; Dean JA; Kelley RI; Kastner DL
    Arthritis Rheum; 2003 Sep; 48(9):2645-51. PubMed ID: 13130485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder.
    Hull KM; Drewe E; Aksentijevich I; Singh HK; Wong K; McDermott EM; Dean J; Powell RJ; Kastner DL
    Medicine (Baltimore); 2002 Sep; 81(5):349-68. PubMed ID: 12352631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial Mediterranean fever successfully treated with etanercept.
    Mor A; Pillinger MH; Kishimoto M; Abeles AM; Livneh A
    J Clin Rheumatol; 2007 Feb; 13(1):38-40. PubMed ID: 17278949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A taste of periodic fever syndromes.
    Koyfman A; Lovallo E; Hazen MM; Chiang VW
    Pediatr Emerg Care; 2013 Jul; 29(7):842-8; quiz 849-51. PubMed ID: 23823268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [From gene to therapy. Hereditary fever syndromes gout and inflammation].
    Lamprecht P
    Z Rheumatol; 2006 Nov; 65(7):610, 612. PubMed ID: 17077976
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment options in colchicine resistant familial Mediterranean fever patients: thalidomide and etanercept as adjunctive agents.
    Seyahi E; Ozdogan H; Celik S; Ugurlu S; Yazici H
    Clin Exp Rheumatol; 2006; 24(5 Suppl 42):S99-103. PubMed ID: 17067437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified regimen of etanercept for tumor necrosis factor receptor associated periodic syndrome (TRAPS) like illness.
    Dhanrajani A; Khubchandani RP
    Indian Pediatr; 2014 Jan; 51(1):55-7. PubMed ID: 24561467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two familial cases with tumor necrosis factor receptor-associated periodic syndrome caused by a non-cysteine mutation (T50M) in the TNFRSF1A gene associated with severe multiorganic amyloidosis.
    Kallinich T; Briese S; Roesler J; Rudolph B; Sarioglu N; Blankenstein O; Keitzer R; Querfeld U; Haffner D
    J Rheumatol; 2004 Dec; 31(12):2519-22. PubMed ID: 15570662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the diagnosis and treatment of tumor necrosis factor receptor-associated periodic syndrome.
    Aguado-Gil L; Irarrazaval-Armendáriz I; Pretel-Irazabal M
    Actas Dermosifiliogr; 2013 Sep; 104(7):617-22. PubMed ID: 23891452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A Dutch family with the hereditary periodic fever or tumour necrosis factor receptor-associated periodic syndrome (TRAPS)].
    Chang Pan Huo NM; Dankert-Roelse JE; Kwee ML
    Ned Tijdschr Geneeskd; 2006 Dec; 150(49):2711-4. PubMed ID: 17194009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic analysis as a valuable key to diagnosis and treatment of periodic Fever.
    Simon A; van Deuren M; Tighe PJ; van der Meer JW; Drenth JP
    Arch Intern Med; 2001 Nov; 161(20):2491-3. PubMed ID: 11700162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyper IgD syndrome (HIDS) associated with in vitro evidence of defective monocyte TNFRSF1A shedding and partial response to TNF receptor blockade with etanercept.
    Arkwright PD; McDermott MF; Houten SM; Frenkel J; Waterham HR; Aganna E; Hammond LJ; Mirakian RM; Tomlin PI; Vijaydurai PI; Cant AJ
    Clin Exp Immunol; 2002 Dec; 130(3):484-8. PubMed ID: 12452839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary periodic fever.
    Drenth JP; van der Meer JW
    N Engl J Med; 2001 Dec; 345(24):1748-57. PubMed ID: 11742050
    [No Abstract]   [Full Text] [Related]  

  • 19. Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-associated periodic syndrome.
    Cantarini L; Lucherini OM; Cimaz R; Baldari CT; Bellisai F; Rossi Paccani S; Laghi Pasini F; Capecchi PL; Sebastiani GD; Galeazzi M
    Int J Immunopathol Pharmacol; 2009; 22(4):1051-8. PubMed ID: 20074469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-interleukin 1 treatment for patients with familial Mediterranean fever resistant to colchicine.
    Ozen S; Bilginer Y; Aktay Ayaz N; Calguneri M
    J Rheumatol; 2011 Mar; 38(3):516-8. PubMed ID: 21159830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.